Integrative Single-Cell RNA-Seq and ATAC-Seq Analysis of Peripheral Mononuclear Cells in Patients With Ankylosing Spondylitis

Genetic studies on ankylosing spondylitis (AS) have identified more than 100 pathogenic genes. Building a bridge between these genes and biologically targeted therapies is the current research hotspot. We integrated single-cell assaying transposase-accessible chromatin sequencing (scATAC-seq) and si...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in immunology Vol. 12; p. 760381
Main Authors: Xu, Huixuan, Yu, Haiyan, Liu, Lixiong, Wu, Hongwei, Zhang, Cantong, Cai, Wanxia, Hong, Xiaoping, Liu, Dongzhou, Tang, Donge, Dai, Yong
Format: Journal Article
Language:English
Published: Switzerland Frontiers Media S.A 22-11-2021
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Genetic studies on ankylosing spondylitis (AS) have identified more than 100 pathogenic genes. Building a bridge between these genes and biologically targeted therapies is the current research hotspot. We integrated single-cell assaying transposase-accessible chromatin sequencing (scATAC-seq) and single-cell RNA sequencing (scRNA-seq) to explore the key genes and related mechanisms associated with AS pathogenesis. We identified 18 cell types in peripheral mononuclear cells from patients with AS and normal controls and summarized the cell-type-specific abnormal genes by scRNA-seq. Interestingly, we found that the pathogenic gene involved in AS progression originated from CD8+ T cells. Moreover, we observed an abnormal tumor TNF pathway mediated by abnormal expression of , , , , and , and scATAC-seq results confirmed the abnormal accessible binding sites of transcriptional factors , , and . The final magnetic bead sorting and quantitative real-time PCR(RT-qPCR) confirmed that , , , and in CD8+ T cells differed in the AS group. Our results revealed a possible mechanism by which abnormally regulates , , and and drives progression, providing a novel perspective from a single cell point of view in AS.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Reviewed by: Paul Martin, The University of Manchester, United Kingdom; Daniella Schwartz, National Institute of Allergy and Infectious Diseases (NIH), United States
Edited by: Maria I. Bokarewa, University of Gothenburg, Sweden
This article was submitted to Autoimmune and Autoinflammatory Disorders, a section of the journal Frontiers in Immunology
ISSN:1664-3224
1664-3224
DOI:10.3389/fimmu.2021.760381